The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees with the regulator’s position and will oppose the FTC’s challenge.
Read about news from healthcare startups Carrum Health, Turing, and new companies in the Illumina Accelerator program.
What You Should Know: – Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics. – Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina will leverage the expertise of Illumina for Startups in… Read More »Illumina, Sequoia Capital China Launches Genomics Incubator in China
This year J.P. Morgan 39th Annual Healthcare Conference was conducted virtually and we witnessed multiple announcements from numerous Biopharma companies An analysis of events and catalysts that were announced at the conference during these days are included in the report. Most of the deals occurred… Read More »Insights+: Key Deals of JP Morgan Healthcare Conference 2021
The two companies are working together to detect instances of the more contagious B.1.1.7 variant in the U.S. After Colorado identified the first case in the U.S. on Dec. 28, more than 60 cases have since been found across the country.
Shots: Microsoft enters collaboration with Illumina, Twist, and Western Digital to establish a roadmap for the industry towards the wider use of DNA data storage. These companies are the founding members of the alliance Ten additional technology leaders join founding members to together advance industry… Read More »Microsoft Collaborates with Twist and Illumina to Advance Data Storage in DNA
Following years of research and investment, liquid biopsies are steadily accumulating FDA approvals. The tests are being used in molecular profiling of solid tumors and as companion diagnostics for targeted cancer therapies.